有価証券レコード · アーカイブ済み四半期
ALLO
Allogene Therapeutics, Inc. · Healthcare · Biotechnology
16追跡対象保有者
0Δ保有者数
74.87M保有株数
$92.84M報告済み評価額
+1新規ポジション
−1解消銘柄
モメンタム指標（同類マネージャー）： 保有者の広がり 0.0% · 株式フロー +1.2% · 新規ネットポジション数 0.0% — 計算式
すべての保有状況データ：追跡対象13Fマネージャーのみ、普通株ポジション、報告期間 Q3 2025
保有状況の推移
| 四半期 | 保有者 | Δ | 株数 | 報告済み評価額 | 新規 | 解消銘柄 |
|---|---|---|---|---|---|---|
| Q2 2026 | 78 | -4 | 183.62M | $382.24M | +6 | −10 |
| Q1 2026 | 84 | +8 | 106.47M | $259.25M | +11 | −3 |
| Q4 2025 | 76 | +2 | 91.09M | $124.76M | +2 | — |
| Q3 2025 | 16 | 0 | 74.87M | $92.84M | +1 | −1 |
| Q2 2025 | 13 | 0 | 69.68M | $78.74M | — | — |
| Q1 2025 | 10 | +1 | 41.70M | $60.89M | +2 | −1 |
| Q4 2024 | 9 | -2 | 35.46M | $75.54M | — | −2 |
| Q3 2024 | 10 | 0 | 29.49M | $82.58M | — | — |
| Q2 2024 | 10 | — | 28.78M | $67.06M | — | — |
保有者情報 · Q3 2025
| # | 運用会社 | 株数 | Δ株式数 | 時価 | そのウェイト | 保有中 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (パッシブ) | 17.51M | -2.1% | $21.72M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 2 | BlackRock ✦ (パッシブ) | 17.51M | -2.1% | $21.72M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 3 | BlackRock ✦ (パッシブ) | 17.51M | -2.1% | $21.72M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 4 | BlackRock ✦ (パッシブ) | 17.51M | -2.1% | $21.72M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 5 | BlackRock ✦ (パッシブ) | 17.51M | -2.1% | $21.72M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | BlackRock ✦ (パッシブ) | 17.51M | -2.1% | $21.72M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 7 | BlackRock ✦ (パッシブ) | 17.51M | -2.1% | $21.72M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 8 | BlackRock ✦ (パッシブ) | 17.51M | -2.1% | $21.72M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 9 | BlackRock ✦ (パッシブ) | 17.51M | -2.1% | $21.72M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | BlackRock ✦ (パッシブ) | 17.51M | -2.1% | $21.72M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 11 | BlackRock ✦ (パッシブ) | 17.51M | -2.1% | $21.72M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 12 | Citadel Advisors ✦ | 13.97M | +36.3% | $17.32M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 13 | Citadel Advisors ✦ | 13.97M | +36.3% | $17.32M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 14 | The Vanguard Group ✦ (パッシブ) | 9.02M | +9.2% | $11.19M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 15 | The Vanguard Group ✦ (パッシブ) | 9.02M | +9.2% | $11.19M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 16 | The Vanguard Group ✦ (パッシブ) | 9.02M | +9.2% | $11.19M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 17 | PRIMECAP Management ✦ | 7.08M | +23.8% | $8.78M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 18 | Geode Capital Management ✦ (パッシブ) | 3.83M | +1.0% | $4.75M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 19 | Geode Capital Management ✦ (パッシブ) | 3.83M | +1.0% | $4.75M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 20 | T. Rowe Price ✦ | 3.68M | -8.8% | $4.56M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 21 | T. Rowe Price ✦ | 3.68M | -8.8% | $4.56M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 22 | Millennium Management ✦ | 3.39M | +125.6% | $4.20M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 23 | Two Sigma Investments ✦ | 3.38M | +109.7% | $4.20M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 24 | Renaissance Technologies ✦ | 2.89M | +73.3% | $3.59M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 25 | State Street Global Advisors ✦ (パッシブ) | 2.76M | +1.2% | $3.42M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 26 | AQR Capital Management ✦ | 1.85M | +2199.0% | $2.30M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 27 | AQR Capital Management ✦ | 1.85M | +2199.0% | $2.30M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 28 | AQR Capital Management ✦ | 1.85M | +2199.0% | $2.30M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 29 | AQR Capital Management ✦ | 1.85M | +2199.0% | $2.30M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 30 | AQR Capital Management ✦ | 1.85M | +2199.0% | $2.30M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 31 | JPMorgan Chase ✦ | 1.82M | — | $2.25M | 0.0% | n/c | 1 | SEC ↗ |
| 32 | JPMorgan Chase ✦ | 1.82M | — | $2.25M | 0.0% | n/c | 1 | SEC ↗ |
| 33 | JPMorgan Chase ✦ | 1.82M | — | $2.25M | 0.0% | n/c | 1 | SEC ↗ |
| 34 | JPMorgan Chase ✦ | 1.82M | — | $2.25M | 0.0% | n/c | 1 | SEC ↗ |
| 35 | JPMorgan Chase ✦ | 1.82M | — | $2.25M | 0.0% | n/c | 1 | SEC ↗ |
| 36 | JPMorgan Chase ✦ | 1.82M | — | $2.25M | 0.0% | n/c | 1 | SEC ↗ |
| 37 | Morgan Stanley ✦ | 1.30M | — | $1.61M | 0.0% | n/c | 1 | SEC ↗ |
| 38 | Morgan Stanley ✦ | 1.30M | — | $1.61M | 0.0% | n/c | 1 | SEC ↗ |
| 39 | Morgan Stanley ✦ | 1.30M | — | $1.61M | 0.0% | n/c | 1 | SEC ↗ |
| 40 | Morgan Stanley ✦ | 1.30M | — | $1.61M | 0.0% | n/c | 1 | SEC ↗ |
| 41 | Morgan Stanley ✦ | 1.30M | — | $1.61M | 0.0% | n/c | 1 | SEC ↗ |
| 42 | Morgan Stanley ✦ | 1.30M | — | $1.61M | 0.0% | n/c | 1 | SEC ↗ |
| 43 | Morgan Stanley ✦ | 1.30M | — | $1.61M | 0.0% | n/c | 1 | SEC ↗ |
| 44 | Goldman Sachs Group ✦ | 1.20M | — | $1.49M | 0.0% | n/c | 1 | SEC ↗ |
| 45 | Goldman Sachs Group ✦ | 1.20M | — | $1.49M | 0.0% | n/c | 1 | SEC ↗ |
| 46 | Fidelity (FMR) ✦ | 710.96K | -27.7% | $881,591 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 47 | Fidelity (FMR) ✦ | 710.96K | -27.7% | $881,591 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 48 | D. E. Shaw & Co. ✦ | 463.90K | 新規 | $575,234 | 0.0% | New | 1 | SEC ↗ |
「当該ウェイト」= そのマネージャーの報告済み13F株式評価額に占めるポジションの割合（確信度の指標）。✦ = キュレーション済みマネージャー。
新規買い手
| D. E. Shaw & Co. | $575,234 | 0.0% |
ポジション解消済み
| Capital World Investors | $12.60M | だった 0.0% |
市場全体のコンテキスト: 全13Fファイラー対象（SEC構造化データ、 Q1 2026): 207 保有者, 182.71M 株式数, $425.90M 報告済み. これは上記の追跡対象ユニバースの数値とは異なる、より古い期間のものであり、両者が混在することはありません。
共同保有が多い銘柄
この有価証券の追跡対象保有者が最も頻繁に保有する他の銘柄 — ファンダメンタルな関係ではなく、共同保有件数に基づきます。